Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trial.
Choi JI, Park YM, Oh YS, Kim JB, Han S, Park JS, On YK, Choi KJ, Hwang GS, Lee MH, Shin DG, Kim NH, Kim DK, Namgung J, Kim DH, Park HW, Park HC, Choi EK, Rhee KS, Shin SY, Kim YH. Choi JI, et al. Among authors: kim yh, kim dh, kim dk, kim jb, kim nh. Heart Rhythm. 2024 Apr 15:S1547-5271(24)02384-1. doi: 10.1016/j.hrthm.2024.04.057. Online ahead of print. Heart Rhythm. 2024. PMID: 38621497 Free article. No abstract available.
Risk factors between patients with lone and non-lone atrial fibrillation.
Lee SH, Park SJ, Byeon K, On YK, Kim JS, Shin DG, Cho JG, Kim YN, Kim YH; KORAF Investigators. Lee SH, et al. J Korean Med Sci. 2013 Aug;28(8):1174-80. doi: 10.3346/jkms.2013.28.8.1174. Epub 2013 Jul 31. J Korean Med Sci. 2013. PMID: 23960444 Free PMC article.
Standard-Intensity Versus Low-Intensity Anticoagulation with Warfarin in Asian Patients with Atrial Fibrillation: A Multi-Center, Randomized Controlled Trial.
Cho JG, Lee KH, Kim YR, Kim S, Gwak J, Cho E, Sin Y, Shin SY, Park HW, Ko JS, Kim NH, Park YM, Lee JM, Yoon NS, Kim SS, Kim JH, Kim DM. Cho JG, et al. Among authors: kim ss, kim s, kim yr, kim dm, kim nh, kim jh. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231171081. doi: 10.1177/10760296231171081. Clin Appl Thromb Hemost. 2023. PMID: 37082789 Free PMC article. Clinical Trial.
Prevalence of electrocardiographic findings suggestive of sudden cardiac death risk in 10,867 apparently healthy young Korean men.
Uhm JS, Hwang IU, Oh YS, Choi MS, Jang SW, Shin WS, Kim JH, Lee MY, Rho TH, Kim YH, Sung JH, Lee YS, Cho JG, Oh DJ, Kim DK, Namgung J, Park KM, Kim YH, Kim YN, Lim HE, Cha TJ, On YK, Shin DG, Pak HN, Kim NH. Uhm JS, et al. Among authors: kim yh, kim yn, kim dk, kim nh, kim jh. Pacing Clin Electrophysiol. 2011 Jun;34(6):717-23. doi: 10.1111/j.1540-8159.2010.03024.x. Epub 2011 Feb 17. Pacing Clin Electrophysiol. 2011. PMID: 21332562
Survival advantage of peritoneal dialysis relative to hemodialysis in the early period of incident dialysis patients: a nationwide prospective propensity-matched study in Korea.
Choi JY, Jang HM, Park J, Kim YS, Kang SW, Yang CW, Kim NH, Cho JH, Park SH, Kim CD, Kim YL; Clinical Research Center for End Stage Renal Disease (CRC for ESRD) Investigators. Choi JY, et al. Among authors: kim cd, kim yl, kim ys, kim nh. PLoS One. 2013 Dec 30;8(12):e84257. doi: 10.1371/journal.pone.0084257. eCollection 2013. PLoS One. 2013. PMID: 24386357 Free PMC article. Clinical Trial.
The Korean Clinical Research Center for End-Stage Renal Disease Study Validates the Association of Hemoglobin and Erythropoiesis-Stimulating Agent Dose with Mortality in Hemodialysis Patients.
Kwon O, Jang HM, Jung HY, Kim YS, Kang SW, Yang CW, Kim NH, Choi JY, Cho JH, Kim CD, Kim YL, Park SH; Clinical Research Center for End-Stage Renal Disease (CRC- ESRD) Investigators. Kwon O, et al. Among authors: kim cd, kim yl, kim ys, kim nh. PLoS One. 2015 Oct 9;10(10):e0140241. doi: 10.1371/journal.pone.0140241. eCollection 2015. PLoS One. 2015. PMID: 26452232 Free PMC article. Clinical Trial.
Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study.
Kwon E, Cho JH, Jang HM, Kim YS, Kang SW, Yang CW, Kim NH, Kim HJ, Park JM, Lee JE, Jung HY, Choi JY, Park SH, Kim CD, Kim YL; Clinical Research Center for End Stage Renal Disease (CRC for ESRD) Investigators. Kwon E, et al. Among authors: kim cd, kim hj, kim yl, kim ys, kim nh. PLoS One. 2015 Aug 11;10(8):e0135476. doi: 10.1371/journal.pone.0135476. eCollection 2015. PLoS One. 2015. PMID: 26263373 Free PMC article.
Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
Na SH, Lee HY, Hong Baek S, Jeon HK, Kang JH, Kim YN, Park CG, Ryu JK, Rhee MY, Kim MH, Hong TJ, Choi DJ, Cho SW, Cha DH, Jeon ES, Kim JJ, Shin JH, Park SH, Lee SH, John SH, Shin ES, Kim NH, Lee SY, Kwan J, Jeong MH, Kim SW, Jeong JO, Kim DW, Lee NH, Park WJ, Ahn JC, Won KH, Uk Lee S, Cho JH, Kim SK, Ahn T, Hong S, Yoo SY, Kim SY, Kim BS, Juhn JH, Kim SY, Lee YJ, Oh BH. Na SH, et al. Among authors: kim jj, kim bs, kim dw, kim sw, kim yn, kim sy, kim sk, kim nh, kim mh. Clin Ther. 2015 Aug;37(8):1726-39. doi: 10.1016/j.clinthera.2015.05.512. Epub 2015 Jul 8. Clin Ther. 2015. PMID: 26164786 Clinical Trial.
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.
Han SY, Yoon SA, Han BG, Kim SG, Jo YI, Jeong KH, Oh KH, Park HC, Park SH, Kang SW, Na KR, Kang SW, Kim NH, Jang Y, Kim B, Shin S, Cha DR. Han SY, et al. Among authors: kim b, kim sg, kim nh. Diabetes Obes Metab. 2018 Feb;20(2):292-300. doi: 10.1111/dom.13059. Epub 2017 Sep 6. Diabetes Obes Metab. 2018. PMID: 28719008 Clinical Trial.
2,277 results